Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127659471 | 12765947 | 1 | I | 20160907 | 20160921 | 20160921 | EXP | PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-124317 | RANBAXY | KLUK MK, WESOLOWSKA K, WORONOWICZ-CHROSCIEL A, WOZAKOWSKA-KAPLON B. CHALLENGING CHOICES IN PATIENTS WITH BOTH HIGH THROMBOEMBOLIC AND BLEEDING RISK-A CLINICAL CASE OF 81-YEAR-OLD WOMAN WITH HIGH RISK OF STROKE AFTER GASTROINTESTINAL BLEEDING EVENT. FOLIA CARDIOL. 2016;11(3):228-232 | 81.00 | YR | F | Y | 0.00000 | 20160921 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127659471 | 12765947 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Unknown | 1 X 20 MG | U | 76477 | |||||||||
| 127659471 | 12765947 | 2 | SS | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 10 MG, BID | U | 0 | 10 | MG | Q12H | ||||||
| 127659471 | 12765947 | 3 | I | Amiodarone | AMIODARONE | 1 | Oral | 1 X 200 MG | Y | 0 | |||||||||
| 127659471 | 12765947 | 4 | SS | Bisoprolol | BISOPROLOL | 1 | Unknown | 1 X 2.5 MG | U | 0 | |||||||||
| 127659471 | 12765947 | 5 | SS | EPLERENONE. | EPLERENONE | 1 | Unknown | 1 X 25 MG | U | 0 | |||||||||
| 127659471 | 12765947 | 6 | SS | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | 1 X 1.5 MG | Y | 0 | |||||||||
| 127659471 | 12765947 | 7 | SS | NAPROXEN. | NAPROXEN | 1 | Unknown | 500 MG X 2-3 / D | U | 0 | |||||||||
| 127659471 | 12765947 | 8 | SS | RANITIDINE. | RANITIDINE | 1 | Unknown | PERIODICALLY USE | U | 0 | |||||||||
| 127659471 | 12765947 | 9 | I | Dabigatran | DABIGATRAN | 1 | Unknown | 150 MG, BID | Y | 0 | 150 | MG | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127659471 | 12765947 | 1 | Product used for unknown indication |
| 127659471 | 12765947 | 2 | Product used for unknown indication |
| 127659471 | 12765947 | 3 | Product used for unknown indication |
| 127659471 | 12765947 | 4 | Product used for unknown indication |
| 127659471 | 12765947 | 5 | Product used for unknown indication |
| 127659471 | 12765947 | 6 | Product used for unknown indication |
| 127659471 | 12765947 | 7 | Osteoarthritis |
| 127659471 | 12765947 | 8 | Product used for unknown indication |
| 127659471 | 12765947 | 9 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127659471 | 12765947 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127659471 | 12765947 | Anaemia | |
| 127659471 | 12765947 | Arthralgia | |
| 127659471 | 12765947 | Condition aggravated | |
| 127659471 | 12765947 | Drug interaction | |
| 127659471 | 12765947 | Gastrointestinal haemorrhage | |
| 127659471 | 12765947 | Helicobacter infection | |
| 127659471 | 12765947 | Hypotension | |
| 127659471 | 12765947 | Melaena | |
| 127659471 | 12765947 | Renal failure | |
| 127659471 | 12765947 | Shock haemorrhagic | |
| 127659471 | 12765947 | Sinus rhythm | |
| 127659471 | 12765947 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |